Is OM or STIM more profitable?

Neuronetics has a net margin of -19.62% compared to Outset Medical's net margin of -63.06%. Outset Medical's return on equity of -61.67% beat Neuronetics' return on equity. Company Net Margins Return on Equity Return on Assets Outset Medical -63.06% -61.67% -28.25% Neuronetics -19.62% -125.11% -22.15%

Which has higher earnings and valuation, PDEX or OM?

Pro-Dex has higher earnings, but lower revenue than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pro-Dex $77.55M 2.97 $13.66M $4.13 17.42 Outset Medical $117.80M 0.49 -$81.65M -$4.09 N/A

Is PDEX or OM more profitable?

Pro-Dex has a net margin of 17.62% compared to Outset Medical's net margin of -63.06%. Pro-Dex's return on equity of 25.13% beat Outset Medical's return on equity. Company Net Margins Return on Equity Return on Assets Pro-Dex 17.62% 25.13% 16.02% Outset Medical -63.06% -61.67% -28.25%

Do analysts rate ZJYL or OM?

Outset Medical has a consensus target price of $10.00, indicating a potential upside of 223.62%. Given Outset Medical's stronger consensus rating and higher possible upside, analysts plainly believe Outset Medical is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Outset Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has stronger earnings and valuation, ZJYL or OM?

Jin Medical International has higher earnings, but lower revenue than Outset Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jin Medical International $20.69M 7.77 $1.19M N/A N/A Outset Medical $117.80M 0.49 -$81.65M -$4.09 N/A

Outset Medical (OM) Competitors

$3.09 -0.20 (-6.08%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$3.07 -0.02 (-0.61%)

As of 04:02 AM Eastern

Compare

OM vs. STIM, ELMD, PDEX, PROF, and ZJYL

Should you buy Outset Medical stock or one of its competitors? Outset Medical's main competitors and comparable companies include Neuronetics (STIM), Electromed (ELMD), Pro-Dex (PDEX), Profound Medical (PROF), and Jin Medical International (ZJYL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Outset Medical compare to Neuronetics?

Outset Medical (NASDAQ:OM) and Neuronetics (NASDAQ:STIM) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability.

Neuronetics has higher revenue and earnings than Outset Medical. Neuronetics is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$117.80M	0.49	-$81.65M	-$4.09	N/A
Neuronetics	$149.16M	1.47	-$39M	-$0.44	N/A

53.6% of Neuronetics shares are held by institutional investors. 2.5% of Outset Medical shares are held by insiders. Comparatively, 8.4% of Neuronetics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Neuronetics has a net margin of -19.62% compared to Outset Medical's net margin of -63.06%. Outset Medical's return on equity of -61.67% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.06%	-61.67%	-28.25%
Neuronetics	-19.62%	-125.11%	-22.15%

In the previous week, Neuronetics had 2 more articles in the media than Outset Medical. MarketBeat recorded 2 mentions for Neuronetics and 0 mentions for Outset Medical. Outset Medical's average media sentiment score of 0.00 equaled Neuronetics'average media sentiment score.

Company	Overall Sentiment
Outset Medical	Neutral
Neuronetics	Neutral

Outset Medical has a beta of 1.9, suggesting that its share price is 90% more volatile than the broader market. Comparatively, Neuronetics has a beta of 1.16, suggesting that its share price is 16% more volatile than the broader market.

Outset Medical currently has a consensus target price of $10.00, indicating a potential upside of 223.62%. Neuronetics has a consensus target price of $4.67, indicating a potential upside of 62.04%. Given Outset Medical's higher probable upside, research analysts clearly believe Outset Medical is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

Neuronetics beats Outset Medical on 11 of the 15 factors compared between the two stocks.

How does Outset Medical compare to Electromed?

Electromed (NYSE:ELMD) and Outset Medical (NASDAQ:OM) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.

Electromed has a beta of 0.46, indicating that its stock price is 54% less volatile than the broader market. Comparatively, Outset Medical has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market.

40.8% of Electromed shares are owned by institutional investors. 10.5% of Electromed shares are owned by insiders. Comparatively, 2.5% of Outset Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Electromed has a net margin of 11.34% compared to Outset Medical's net margin of -63.06%. Electromed's return on equity of 15.71% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
Outset Medical	-63.06%	-61.67%	-28.25%

Electromed presently has a consensus price target of $43.75, indicating a potential upside of 58.69%. Outset Medical has a consensus price target of $10.00, indicating a potential upside of 223.62%. Given Outset Medical's higher probable upside, analysts plainly believe Outset Medical is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, Electromed's average media sentiment score of 0.00 equaled Outset Medical'saverage media sentiment score.

Company	Overall Sentiment
Electromed	Neutral
Outset Medical	Neutral

Electromed has higher earnings, but lower revenue than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$73.78M	3.13	$5.15M	$1.31	21.05
Outset Medical	$117.80M	0.49	-$81.65M	-$4.09	N/A

Summary

Electromed beats Outset Medical on 10 of the 13 factors compared between the two stocks.

How does Outset Medical compare to Pro-Dex?

Pro-Dex (NASDAQ:PDEX) and Outset Medical (NASDAQ:OM) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

Pro-Dex has a net margin of 17.62% compared to Outset Medical's net margin of -63.06%. Pro-Dex's return on equity of 25.13% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pro-Dex	17.62%	25.13%	16.02%
Outset Medical	-63.06%	-61.67%	-28.25%

In the previous week, Pro-Dex had 6 more articles in the media than Outset Medical. MarketBeat recorded 6 mentions for Pro-Dex and 0 mentions for Outset Medical. Pro-Dex's average media sentiment score of 1.09 beat Outset Medical's score of 0.00 indicating that Pro-Dex is being referred to more favorably in the media.

Company	Overall Sentiment
Pro-Dex	Positive
Outset Medical	Neutral

Pro-Dex currently has a consensus price target of $74.00, indicating a potential upside of 2.86%. Outset Medical has a consensus price target of $10.00, indicating a potential upside of 223.62%. Given Outset Medical's higher possible upside, analysts clearly believe Outset Medical is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Pro-Dex has a beta of 0.06, suggesting that its stock price is 94% less volatile than the broader market. Comparatively, Outset Medical has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market.

Pro-Dex has higher earnings, but lower revenue than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$77.55M	2.97	$13.66M	$4.13	17.42
Outset Medical	$117.80M	0.49	-$81.65M	-$4.09	N/A

15.3% of Pro-Dex shares are owned by institutional investors. 45.9% of Pro-Dex shares are owned by insiders. Comparatively, 2.5% of Outset Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Pro-Dex beats Outset Medical on 13 of the 17 factors compared between the two stocks.

How does Outset Medical compare to Profound Medical?

Outset Medical (NASDAQ:OM) and Profound Medical (NASDAQ:PROF) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations.

Outset Medical presently has a consensus price target of $10.00, indicating a potential upside of 223.62%. Profound Medical has a consensus price target of $11.50, indicating a potential upside of 100.35%. Given Outset Medical's higher probable upside, equities analysts clearly believe Outset Medical is more favorable than Profound Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Profound Medical has lower revenue, but higher earnings than Outset Medical. Profound Medical is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$117.80M	0.49	-$81.65M	-$4.09	N/A
Profound Medical	$19.09M	10.99	-$42.57M	-$0.98	N/A

In the previous week, Outset Medical's average media sentiment score of 0.00 equaled Profound Medical'saverage media sentiment score.

Company	Overall Sentiment
Outset Medical	Neutral
Profound Medical	Neutral

Outset Medical has a net margin of -63.06% compared to Profound Medical's net margin of -171.57%. Outset Medical's return on equity of -61.67% beat Profound Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.06%	-61.67%	-28.25%
Profound Medical	-171.57%	-63.03%	-51.24%

Outset Medical has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market. Comparatively, Profound Medical has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market.

47.9% of Profound Medical shares are owned by institutional investors. 2.5% of Outset Medical shares are owned by company insiders. Comparatively, 1.5% of Profound Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Outset Medical beats Profound Medical on 9 of the 15 factors compared between the two stocks.

How does Outset Medical compare to Jin Medical International?

Jin Medical International (NASDAQ:ZJYL) and Outset Medical (NASDAQ:OM) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, media sentiment, institutional ownership and valuation.

In the previous week, Jin Medical International's average media sentiment score of 0.00 equaled Outset Medical'saverage media sentiment score.

Company	Overall Sentiment
Jin Medical International	Neutral
Outset Medical	Neutral

Jin Medical International has a net margin of 0.00% compared to Outset Medical's net margin of -63.06%. Jin Medical International's return on equity of 0.00% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
Outset Medical	-63.06%	-61.67%	-28.25%

Outset Medical has a consensus target price of $10.00, indicating a potential upside of 223.62%. Given Outset Medical's stronger consensus rating and higher possible upside, analysts plainly believe Outset Medical is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Jin Medical International has a beta of 7.31, meaning that its stock price is 631% more volatile than the broader market. Comparatively, Outset Medical has a beta of 1.9, meaning that its stock price is 90% more volatile than the broader market.

Jin Medical International has higher earnings, but lower revenue than Outset Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$20.69M	7.77	$1.19M	N/A	N/A
Outset Medical	$117.80M	0.49	-$81.65M	-$4.09	N/A

Summary

Jin Medical International beats Outset Medical on 6 of the 10 factors compared between the two stocks.

Get Outset Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OM vs. The Competition

Export

Metric	Outset Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$61.84M	$5.58B	$7.31B	$13.29B
Dividend Yield	N/A	1.79%	2.52%	12.57%
P/E Ratio	-0.76	25.26	274.08	25.69
Price / Sales	0.49	71.56	638.21	78.99
Price / Cash	N/A	33.02	77.80	52.76
Price / Book	0.44	5.78	10.47	6.32
Net Income	-$81.65M	$151.55M	$3.49B	$359.73M
7 Day Performance	-0.32%	-0.01%	-0.67%	0.17%
1 Month Performance	-26.25%	-3.53%	-3.17%	-3.27%
1 Year Performance	-79.11%	6.37%	15.14%	5.58%

Outset Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OM Outset Medical	2.3431 of 5 stars	$3.09 -6.1%	$10.00 +223.6%	-79.2%	$61.84M	$117.80M	N/A	310
STIM Neuronetics	3.4622 of 5 stars	$2.80 -3.4%	$4.67 +66.7%	+4.7%	$221.35M	$149.16M	N/A	658
ELMD Electromed	2.3085 of 5 stars	$26.29 -0.4%	$43.75 +66.4%	+15.5%	$219.94M	$73.78M	35.05	197
PDEX Pro-Dex	3.7512 of 5 stars	$66.91 +0.5%	$74.00 +10.6%	+112.1%	$213.21M	$77.55M	16.20	206	Analyst Downgrade
PROF Profound Medical	2.5577 of 5 stars	$5.68 -2.2%	$11.50 +102.5%	+13.4%	$212.25M	$16.10M	N/A	162

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OM) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Outset Medical (OM) Competitors

OM vs. STIM, ELMD, PDEX, PROF, and ZJYL

How does Outset Medical compare to Neuronetics?

Summary

How does Outset Medical compare to Electromed?

Summary

How does Outset Medical compare to Pro-Dex?

Summary

How does Outset Medical compare to Profound Medical?

Summary

How does Outset Medical compare to Jin Medical International?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OM vs. The Competition

Outset Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Outset Medical (OM) Competitors

OM vs. STIM, ELMD, PDEX, PROF, and ZJYL

How does Outset Medical compare to Neuronetics?

Which has higher earnings and valuation, OM or STIM?

Do institutionals and insiders believe in OM or STIM?

Is OM or STIM more profitable?

Does the media refer more to OM or STIM?

Which has more volatility & risk, OM or STIM?

Do analysts recommend OM or STIM?

Summary

How does Outset Medical compare to Electromed?

Which has more volatility and risk, ELMD or OM?

Do insiders & institutionals believe in ELMD or OM?

Is ELMD or OM more profitable?

Do analysts recommend ELMD or OM?

Does the media favor ELMD or OM?

Which has stronger earnings and valuation, ELMD or OM?

Summary

How does Outset Medical compare to Pro-Dex?

Is PDEX or OM more profitable?

Does the media favor PDEX or OM?

Do analysts rate PDEX or OM?

Which has more risk & volatility, PDEX or OM?

Which has higher earnings and valuation, PDEX or OM?

Do institutionals & insiders hold more shares of PDEX or OM?

Summary

How does Outset Medical compare to Profound Medical?

Do analysts recommend OM or PROF?

Which has higher earnings and valuation, OM or PROF?

Does the media refer more to OM or PROF?

Is OM or PROF more profitable?

Which has more volatility & risk, OM or PROF?

Do institutionals and insiders believe in OM or PROF?

Summary

How does Outset Medical compare to Jin Medical International?

Does the media refer more to ZJYL or OM?

Is ZJYL or OM more profitable?

Do analysts rate ZJYL or OM?

Which has more volatility & risk, ZJYL or OM?

Which has stronger earnings and valuation, ZJYL or OM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OM vs. The Competition

Outset Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools